Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Sclerosis Systemic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02465437
What this trial is testing

Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 42
Not applicableStudy completedNCT04179292
What this trial is testing

The Effect of Physiotherapy Program in Scleroderma Patients

Who this might be right for
SclerodermaSystemic SclerosisHand Rheumatism+2 more
Istanbul University 40
Testing effectiveness (Phase 2)Ended earlyNCT05626751
What this trial is testing

An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 174
Not applicableWithdrawnNCT02328625
What this trial is testing

Scleroderma Treatment With Celution Processed ADRCs Registry

Who this might be right for
Scleroderma
Cytori Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Not applicableStudy completedNCT01758250
What this trial is testing

Microvascular and Fibrosis Imaging Study

Who this might be right for
Autoimmune DiseasesSickle Cell DiseaseChronic Graft Versus Host Disease
Duke University 63
Not applicableStudy completedNCT06646913
What this trial is testing

TENS in Scleroderma

Who this might be right for
SclerodermaGastroparesisSystemic Sclerosis (SSc)
University of Michigan 11
Large-scale testing (Phase 3)Ended earlyNCT02374320
What this trial is testing

Exparel as a Nerve Block for Severe Hand Pain

Who this might be right for
CREST SyndromePeripheral Vascular DiseaseRaynaud Disease+1 more
Jose Soberon, MD 13
Testing effectiveness (Phase 2)UnknownNCT00769028
What this trial is testing

AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Daval International Limited 20
Testing effectiveness (Phase 2)Ended earlyNCT00377455
What this trial is testing

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Who this might be right for
Systemic SclerodermaPulmonary Hypertension
Georgetown University 5
Testing effectiveness (Phase 2)Looking for participantsNCT06195072
What this trial is testing

Platform Clinical Study for Conquering Scleroderma

Who this might be right for
Interstitial Lung Disease Due to Systemic DiseaseScleroderma
Scleroderma Research Foundation, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT02915835
What this trial is testing

Riociguat in Scleroderma Associated Digital Ulcers

Who this might be right for
SclerodermaDigital Ulcers
Dinesh Khanna, MD, MS 17
Post-approval studies (Phase 4)Study completedNCT00048776
What this trial is testing

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Very early researchWithdrawnNCT04656704
What this trial is testing

Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

Who this might be right for
MicrostomiaSclerodermaCREST Syndrome+2 more
Brigham and Women's Hospital
Not applicableEnded earlyNCT04567537
What this trial is testing

Laser Treatment for the Improvement of Scars and Scleroderma

Who this might be right for
ScarsScleroderma
Massachusetts General Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Not applicableNo Longer AvailableNCT01374282
What this trial is testing

Post Marketing Surveillance Study of Cuprimine

Who this might be right for
Scleroderma
Merck Sharp & Dohme LLC
Not applicableLooking for participantsNCT03276923
What this trial is testing

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Who this might be right for
Autoimmune DiseasesPregnancy RelatedSystemic Lupus Erythematosus+4 more
Duke University 1,000
Post-approval studies (Phase 4)Ended earlyNCT03388255
What this trial is testing

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Who this might be right for
Scleroderma Disease
Mastelli S.r.l 25
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Next Page